← FDA DRUG APPROVALS

FDA ANDA · ANDA089143

METHYLPREDNISOLONE SODIUM SUCCINATE

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA089143
TYPE
ANDA
ORIGINAL APPROVAL
1986-03-28
LATEST ACTION
1989-10-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METHYLPREDNISOLONE SODIUM SUCCINATEDiscontinued
METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1989-10-26Labeling · Supplement 4AP
1986-03-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →